Andere Sprachen Ascendis Pharma A/S

Aktien

A14M6X

US04351P1012

ASND

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:58:53 01.05.2024			% 5 Tage	% 1. Jan.
142,6 ^USD	+2,97 %		-1,32 %	+12,18 %

29.04.	Europäische Aktien werden in den USA als American Depositary Receipts gehandelt und steigen im Montagshandel leicht an	MT
26.04.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Freitagshandel höher und beenden die Woche mit einem Plus von 3,4%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	29.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26.04.
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024	25.04.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25.04.
Ascendis Pharma - United Kingdom's MHRA Approves YORVIPATH in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism	25.04.
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism	24.04.
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism	24.04.
Ascendis Pharma A/S Announces United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism	24.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19.04.
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	18.04.
Ascendis Pharma A/S : Form 6-K	10.04.
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28.03.
Ascendis Pharma A/S : Form 6-K	27.03.
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21.03.
Ascendis Pharma A/S : Form 6-K	14.03.
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13.03.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	12.03.
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024	04.03.
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer	29.02.
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading	16.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ascendis Pharma A/S

Aktien

A14M6X

US04351P1012

ASND

Andere Sprachen

Filter